Clinical Scorecard: Assessment of Global Skin Cancer Impact from 1990 to 2023 with Future Projections for 2050

At a Glance

Key Highlights

• Melanoma prevalence highest in Oceania, with significant increases in low- and middle-SDI regions.
• Squamous cell carcinoma DALYs increased notably in low-SDI settings.
• Basal cell carcinoma remains stable but shows increases in specific regions like East Asia.
• Male prevalence rates higher across all skin cancers, with notable declines in melanoma prevalence from 2010 to 2023.
• Projections indicate significant increases in DALYs for all three skin cancers by 2050.

Guideline-Based Recommendations

Diagnosis

• Utilize epidemiological data to inform screening and diagnostic practices.

Management

• Focus on enhancing health care access and screening in low- and middle-SDI regions.

Monitoring & Follow-up

• Implement routine skin examinations and public awareness campaigns in high-SDI regions.

Risks

• Underdiagnosis in low- and middle-SDI settings due to limited health care resources.

Patient & Prescribing Data

Individuals at risk for malignant skin cancers, particularly in low- and middle-SDI regions.

Increased burden in low- and middle-SDI regions necessitates improved health care infrastructure.

Clinical Best Practices

• Encourage routine skin examinations in populations at higher risk.
• Enhance public health policies to improve access to dermatological care.
• Utilize data-driven approaches to tailor interventions based on regional epidemiology.

Related Resources & Content

• Global Burden of Disease (GBD) 2023 database
• United States Cancer Statistics (1999-2021)
• Australian cancer surveillance data